Sign inJoin waitlistJoin the waitlist

Sam Lubner

Internal Medicine Residency · University of Wisconsin Hospitals and Clinics

Credentials: · · ·

History

Internal Medicine
University of Wisconsin Hospitals and Clinics
2024–Present
Hematology and Medical Oncology
2027–2030
University of Wisconsin School of Medicine and Public Health
1999–2003

Research

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
The Lancet Oncology · 2020 · 904 citations
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial
JAMA Oncology · 2021 · 418 citations
CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes
Abdominal Imaging · 2015 · 233 citations

Noelle LoConte
25 papers · 7 as a resident
Dustin Deming
19 papers · 1 as a fellow
Dan Mulkerin
16 papers
Nataliya Uboha
12 papers · 5 as a resident
Jeremy Kratz
11 papers · 7 as a resident
Kristina Matkowskyj
8 papers
KH
Kyle Holen
8 papers
Meghan Lubner
8 papers
Michael Bassetti
8 papers · 2 as a resident
Perry Pickhardt
7 papers
Daniel Abbott
6 papers
WS
William Schelman
6 papers

Clinical trials

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Site PI · Recruiting · Phase 2, Phase 3
National Cancer Institute (NCI)
2024–2027